Laboratory of Experimental and Clinical Neurosurgery, Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland.
Faculty of Physical Education and Health Promotion, University of Szczecin, Szczecin, Poland.
Clin Exp Pharmacol Physiol. 2020 May;47(5):759-764. doi: 10.1111/1440-1681.13242. Epub 2020 Jan 22.
Hyponatraemia, a water-electrolyte disorder diagnosed in patients with subarachnoid haemorrhage (SAH), increases a risk of persistent vasospasm. In majority of cases, hyponatraemia results from inappropriate secretion of vasopressin (AVP). The effect of AVP-associated hyponatraemia on cerebral vasculature is unknown. The present study aimed to elucidate the role of AVP in the response of the middle cerebral artery (MCA) of the rat to hyponatraemia. Isolated, cannulated, and pressurized rat MCAs were perfused/superfused with physiological (Na = 144 mmol/L) buffer or low-sodium (Na = 121 mmol/L) buffer containing either AVP or angiotensin II (ANG II). ANG II was used to check if the effect of low plasma sodium concentration combined with AVP on the MCA tone is unique to vasopressin. At physiological Na concentration, vasopressin (1.4 × 10 mol/L) or angiotensin II (10 mol/L) resulted in relaxation of the MCA. Substitution of low-sodium for the normal sodium buffer with the same concentration of AVP, resulted in the constriction of the MCA. This effect was absent after removal of the endothelium, administration of vasopressin V receptor antagonist or concomitant inhibition of endothelin-1 receptors and synthesis of thromboxane A In contrast, no constriction of the MCA in low-sodium buffer was observed when AVP was replaced with ANG II. Our data suggest that presence of vasopressin and low sodium ion concentration results in the change of endothelium phenotype from pro-vasodilatory to pro-vasoconstrictory. This phenomenon may be an overlooked factor contributing to vasospasm in SAH patients with hyponatraemia caused by inappropriate antidiuretic hormone secretion (SIADH).
低钠血症是蛛网膜下腔出血(SAH)患者中诊断出的一种水-电解质紊乱,会增加持续性血管痉挛的风险。在大多数情况下,低钠血症是由于抗利尿激素(AVP)分泌不当引起的。AVP 相关低钠血症对脑血管的影响尚不清楚。本研究旨在阐明 AVP 在大鼠大脑中动脉(MCA)对低钠血症反应中的作用。用生理(Na = 144mmol/L)缓冲液或含有 AVP 或血管紧张素 II(ANG II)的低钠(Na = 121mmol/L)缓冲液灌流/孵育分离的、插管的和加压的大鼠 MCA。使用 ANG II 检查低血浆钠浓度与 AVP 结合对 MCA 张力的影响是否仅对加压素有特异性。在生理 Na 浓度下,加压素(1.4×10 )或血管紧张素 II(10 )可使 MCA 松弛。用含有相同浓度 AVP 的低钠缓冲液代替正常钠缓冲液,导致 MCA 收缩。去除内皮后,给予加压素 V 受体拮抗剂或同时抑制内皮素-1 受体和血栓素 A 合成,这种作用消失。然而,当用 ANG II 替代 AVP 时,在低钠缓冲液中没有观察到 MCA 的收缩。我们的数据表明,加压素和低钠离子浓度的存在导致内皮表型从促血管扩张变为促血管收缩。这种现象可能是导致 SAH 患者低钠血症(由不当抗利尿激素分泌引起的 SIADH)并发血管痉挛的一个被忽视的因素。